Oct 30, 2025 06:20AM
Jun 2, 2025 07:30AM
Feb 15, 2025 10:00PM
Jul 23, 2024 07:30AM
Jul 23, 2024 07:30AM
Jun 6, 2024 07:30AM
May 30, 2024 05:36AM Goldman Sachs Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Jul 18, 2023 07:37AM
Mar 8, 2023 07:01AM
Mar 8, 2023 07:00AM
Mar 8, 2023 07:00AM
Mar 6, 2023 04:06PM
Mar 6, 2023 04:06PM
Mar 6, 2023 04:05PM BridgeBio Pharma Announces Proposed Public Offering of Common Stock
Mar 6, 2023 04:05PM
Jul 26, 2022 12:19PM
Dec 28, 2021 04:02AM
Aug 18, 2021 07:36AM
Aug 18, 2021 07:30AM
Mar 22, 2021 11:21AM
Feb 12, 2021 08:04AM BridgeBio Pharma Inc. (BBIO) Announces Pricing of 3M Share Secondary Offering of Common Stock at $62.50/sh
Feb 12, 2021 08:00AM
Feb 12, 2021 08:00AM
Feb 11, 2021 04:12PM
Feb 11, 2021 04:10PM
Feb 11, 2021 04:09PM
Feb 11, 2021 04:09PM
Feb 9, 2021 05:56AM UPDATE: Goldman Sachs Reinstates BridgeBio Pharma (BBIO) at Buy
Dec 11, 2020 10:13AM
Oct 5, 2020 07:06AM
Mar 24, 2020 12:48PM
Jul 22, 2019 02:28AM
Jun 27, 2019 11:08AM
Jun 27, 2019 06:22AM
Jun 26, 2019 11:23PM BridgeBio Pharma Announces Pricing of Its Initial Public Offering

176,323 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All